Adverse effects of aluminium-chelating compounds for clinical use.
Domingo
J L
JL
Laboratory of Toxicology and Environmental Health, School of Medicine, Rovira i Virgili University, Reus, Spain.
D000535:Aluminum / Q000009:adverse effects* / Q000493:pharmacokinetics*; D000818:Animals; D000931:Antidotes / Q000009:adverse effects*; D002614:Chelating Agents / Q000009:adverse effects* / Q000493:pharmacokinetics*; D000077543:Deferiprone; D003676:Deferoxamine / Q000009:adverse effects*; D006801:Humans; D011728:Pyridones / Q000633:toxicity*
D000931:Antidotes; D002614:Chelating Agents; D011728:Pyridones; D000077543:Deferiprone; D000535:Aluminum; D003676:Deferoxamine